CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 161 filers reported holding CLOVIS ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,380,000 | -74.6% | 2,000,000 | -61.5% | 0.06% | -84.2% |
| Q2 2022 | $9,360,000 | +311.4% | 5,200,000 | +919.6% | 0.40% | +129.3% |
| Q3 2021 | $2,275,000 | -85.1% | 510,000 | -80.6% | 0.17% | -79.1% |
| Q2 2021 | $15,225,000 | +1949.1% | 2,625,000 | +5150.0% | 0.83% | +413.0% |
| Q2 2019 | $743,000 | -14.4% | 50,000 | +42.9% | 0.16% | -33.9% |
| Q1 2019 | $868,000 | -59.6% | 35,000 | -70.8% | 0.24% | -83.3% |
| Q4 2018 | $2,151,000 | – | 119,800 | – | 1.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |